Growth Metrics

Biofrontera (BFRI) Cash from Operations (2020 - 2025)

Biofrontera has reported Cash from Operations over the past 6 years, most recently at 2415000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 137.46% year-over-year to 2415000.0; the TTM value through Dec 2025 reached 13400000.0, down 30.48%, while the annual FY2025 figure was 13400000.0, 30.48% down from the prior year.
  • Cash from Operations for Q4 2025 was 2415000.0 at Biofrontera, up from 3785000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 125000.0 in Q2 2022 and troughed at 20990000.0 in Q4 2021.
  • A 5-year average of 4574250.0 and a median of 3384000.0 in 2021 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: skyrocketed 111.83% in 2022 and later tumbled 8360.0% in 2023.
  • Year by year, Cash from Operations stood at 20990000.0 in 2021, then surged by 60.59% to 8272000.0 in 2022, then dropped by 7.24% to 8871000.0 in 2023, then soared by 88.54% to 1017000.0 in 2024, then crashed by 137.46% to 2415000.0 in 2025.
  • Business Quant data shows Cash from Operations for BFRI at 2415000.0 in Q4 2025, 3785000.0 in Q3 2025, and 3100000.0 in Q2 2025.